Abstract: A simple, accurate and reliable method for direct electrothermal atomic absorption spectrometric (ETAAS) determination of chromium in serum and urine samples without any preliminary sample pretreatment is described. Instrumental parameters are optimized in order to define: the most suitable atomizer, optimal temperature program and efficient modifier. An appropriate quantification method is proposed taking into account a matrix interference study. Pyrocoated graphite tubes and wall atomization, pretreatment temperature of 700
Introduction
Chromium is one of the essential trace elements in the human body as it appears to play a role in the metabolism of glucose and some lipids (mainly cholesterol) [1, 2] . Excessive amounts of the element [3] [4] [5] , particularly in the more toxic Cr(VI) oxidation state [6] [7] [8] [9] [10] , is detrimental to health as it may be involved in the pathogenesis of some diseases like lung and gastrointestinal cancers. The routes by which chromium enters the body are the digestive tract, respiratory system and skin. Chromium is excreted principally in the urine, and in small amounts in the hair. Therefore urinary excretion values are a good indicator of the ingestion of chromium, but not necessarily of its body burden. More accurate information could be obtained by analyzing blood, serum and other tissue samples.
Electrothermal atomic absorption spectrometry (ETAAS) is probably one of the most selective and sensitive techniques used for chromium determination in body fluids [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . However, typical Cr content in body fluids of healthy subjects is very close to the detection limit for this method and very careful optimization and control of instrumental parameters as well as of matrix interferences is required for accurate and reliable analysis. Thus, it is worth mentioning that different approaches and conclusions, in some cases ambiguous, have been reported. Accurate chromium determination depends on two very important points: (i) -strict contamination/blank control and (ii) -reliable background correction. The purpose of this investigation was to study and to propose optimal instrumental parameters for the direct ETAAS determination of chromium in serum and urine. The parameters studied and optimized includeed a suitable atomizer, temperature program and an efficient modifier. As a second step, a careful evaluation of matrix interferences and a recommendation for an appropriate calibration procedure for Cr quantification in serum and urine. Finally, a method validation and application for the analysis of serum and urine samples from healthy persons from Macedonia and an analysis of serums from patients on dialysis.
Experimental

Instrumentation
The atomic absorption spectrometer Varian SpectrAA 640Z Zeeman AAS equipped with GTA100 graphite furnace (Varian, USA) and PSD-100 autosampler (Varian, USA) was used. Pyrolytically coated graphite tubes and tubes with centre fixed platforms were used as atomizers. Peak area was used for quantification. Sample aliquots of 10 µL and 10 µL modifier solution were injected. Washing solution for autosampler capillary between samples and modifier injections was 0.2% (v/v) HNO 3 . Precautions to minimize tube memory effects and cross-contamination have been taken. Optimal instrumental parameters are given in Table 1 . The following certified reference materials were used for the validation purposes: Clin Rep. Level 1 serum (Recipe, Germany) and Lypochek Urine Metals Control Level 1 (Lot 69031, Bio Rad, Germany).
All disposable devices were rigorously cleaned before use by brief immersion in hot concentrated nitric acid and rinsing twice with distilled water.
Serum and urine samples were obtained from 21 presumable healthy volunteers along with additional serum samples from 10 dialysis patients. The serum samples were collected with plastic iv kanula No. 24 (TIK, Slovenia) with an injection valve. Urine samples were taken as spot samples. The samples were acidified till pH 2 and kept frozen until analysis.
Procedure
The serum or urine samples of 10 µL were directly introduced into the graphite furnace with 10 µL matrix modifier solution.
The calibration curves were prepared with 1-5 µg/L working standard solutions of Cr.
Results and discussion
Selection of chemical modifier
Several preliminary experiments were carried out to select an efficient chemical modifier for the measurement of Cr in urine and serum. The modifiers tested are: H 2 O 2 (10 %, v/v), HNO 3 (0.1 M) and Mg(NO 3 ) 2 (100 µg/mL). Typically, relatively high pyrolysis temperatures could be used for chromium determination, so the action of the modifier is to assist and ensure complete matrix mineralization and removal during the ashing step. From this point of view, H 2 O 2 is very useful due to its high oxidative potential and active oxygen evolution. It was observed that in the presence of H 2 O 2 , the nonspecific absorbance signals were remarkably lower and the build up of carboneous residue was almost completely avoided, therefore this modifier was selected for all further investigations.
Optimization of temperature program for ETAAS
The optimal temperature program for ETAAS determination of Cr was defined on the base of pretreatment and atomization curves constructed for serum and urine samples previously spiked with 4 µg/L Cr. Ashing temperatures (from 400 • C to 1700
• C) and atomization temperatures (from 2100 • C to 2700
• C) were assayed by using wall atomization (pyrolytically graphite coated graphite tubes) and platform atomization (tubes with centre fixed platforms). Results obtained are summarized in Fig. 1 . Unexpectedly, by using relatively lower pretreatment temperatures of around 700-800
• C , better shaped absorbance/time profiles for the signals as well as lower values for nonspecific absorbance signals were observed. The reproducibility achieved in this case was much better than when higher pyrolysis temperatures were used. This conclusion is valid for both serum and urine samples and for both atomizers studied. As can be expected for an element like Cr, atomization curves ( Fig. 1) showed that, at elevated atomization temperatures higher absorbance signals were observed. For the center fixed platform, the plateau region in the atomization curve is not achieved even when highest possible temperatures are used. It is worth mentioning that this atomizer is not suitable for chromium determination in serum and urine samples, the sensitivity and the reproducibility achieved are lower and the nonspecific absorbance values are higher in comparison with wall atomization.
Calibration
The degree of matrix interferences on ETAAS determination of Cr was evaluated through the ratio (b m /b o ) of the slopes of the calibration curves obtained in the presence of serum or urine (b m ) and in the presence of an aqueous standard solution (b o ). Two types of spiking procedures were used, a series of urine and serum samples were spiked directly into the graphite furnace by using autosampler facilities and series of urine and serum samples were mixed previously with a known amount of Cr and then injected into the graphite furnace. Results obtained for both series are presented in Table 2 and clearly illustrate a strong matrix depression. In the presence of a matrix modifier there is a slight improvement and a decrease in matrix interferences. Once again, it was confirmed that the center fixed platform is not a suitable atomizer for Cr determination in serum and urine since it gave significantly lower values for the ratio b m /b o in all cases studied. It is worth mention that the matrix depression effect is much more pronounced for previously spiked samples than for samples spiked directly into the graphite furnace. It might be assumed that some chemical reaction between Cr and sample components take place and only previously spiked serum and urine samples represent real standard addition. Evidently, the method of standard addition should be used for calibration and preliminary standard additions should be prepared by adding a Cr standard to the serum or urine samples. The autosampler facilities to prepare standard additions should not be used for standard addition preparation. It is known that matrix components contents in serum and urine of different persons slightly varied and it might be expected that a diverse degree of depression on Cr determination would be observed for different serum and urine samples. However, experiments performed with around 15 samples of serum and urine have shown that in all these cases, statistically equal slopes of standard addition calibration curves were obtained, which means that standard additions prepared to at least one of the serum or urine sample is enough to prepare a regression equation valid for Cr quantification in all serums or urines. 
Method validation
The accuracy of the method proposed was checked by comparative analysis of parallel samples after preliminary wet or dry digestion. Very good agreement was found between the results obtained (Table 3) , for all samples analyzed Student's t value is lower than critical. Two certified reference materials of serum and urine were also analyzed to verify the accuracy and reliability of the recommended method for ETAAS determination of Cr in serum and urine. Results obtained (Table 4) 
Application of the method
The method was applied to the determination of Cr in serum and urine samples of 21 presumably healthy volunteers, and in serum samples of 10 patients on dialysis (Table 5) . For 21 non-exposed persons Cr content in serum ranges from 0.08-0.36 µg/L and in urine this range is 0.08-0.90 µg/L. Chromium content in the serum obtained from patients on dialysis is statistically higher with the range 2.14-4.24 µg/L. 
Conclusions
A simple and fast method for direct ETAAS determination of Cr in serum and urine has been developed. The established procedure does not require any sample pre-treatment thus minimizing the risk of contamination. Wall atomization, H 2 O 2 as modifier and standard addition method for calibration are recommended. Detection limits achieved by the proposed procedure are very close to the detection limits obtained by the SF ICP-MS [26, 27] .
